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ABSTRACT
Background: Reduced exercise capacity in diabetics has
been attributed to limitations in cardiac function and
microvascular dysfunction leading to impaired oxygen
supply and nutritive perfusion to exercising muscles.
Objective: To study changes in cardiac function and
microvascular utilisation during exercise in diabetic
individuals compared to age-matched controls.
Methods: Diabetics with glycosylated haemoglobin
(HbA1c) ,8 (n=31), diabetics with HbA1c >8 (n=38)
and age-matched non-diabetic controls (n=32) per-
formed exercise at 50 W for 10 minutes followed by
recovery, with continuous monitoring of cardiac function
by impedance cardiography and regional flow and oxygen
saturation by laser Doppler and white light spectroscopy.
Results: In the diabetics, cardiac reserve during exercise
and cardiac overshoot during recovery are significantly
reduced because of reduction in capacity to increase
stroke volume. Regional flow to the exercising muscle is
reduced and there is also disproportionately greater
desaturation of the regional flow. Abnormalities in cardiac
function and regional perfusion are related to the severity
of diabetes.
Conclusion: Cardiac response to exercise is attenuated
significantly in diabetic individuals. Simultaneously, there
is impairment in the regional distribution. These changes
could be the harbinger of reduced exercise capacity in
diabetics.
Clinical studies have shown that limitation in
exercise capacity is a strong predictor of cardiovas-
cular and all-cause mortality in diabetic patients
with heart failure. Underlying pathophysiology is
multifactorial and involves alterations in ventricu-
lar-vascular coupling consisting of cardiac changes
on the one hand and compromised distribution at
the regional microvasculature on the other. If such
changes can be detected early (stage A) in those
who are at risk of progressing to heart failure, it
may help slow down progression by more aggres-
sive management of the problem.
Though there is fair body of evidence on the
mechanism underlying the decline in exercise
tolerance and despite the recognition of its prog-
nostic significance, monitoring microvascular
changes underlying altered skeletal muscle exercise
capacity and mapping them dynamically against
cardiac response capacity has not been attempted.
Monitoring of regional alterations in the micro-
circulation in patients is restricted by the invasive
character of methodology and limitations to its
adaptation to record continuous and dynamic
change in the exercising muscle. Assessing cardiac
function during exercise poses a special challenge as
conventional echocardiographic measures includ-
ing strain analysis, can only be done at rest or at
the end of exercise. Therefore dynamic response to
exercise, which is a function of continuous adjust-
ment of pre-load (Frank-Starling) and after-load as
well as direct cardiac adrenergic influence, designed
to optimise the inotropic and chronotropic
responses, cannot be captured by these methods.
Impedance cardiography (ICG) has been vali-
dated to gather ambulatory physiological record-
ings and was adapted to monitor cardiac function
online during exercise.
12For monitoring regional
microcirculation this was combined with another
method where laser Doppler shift caused by the
movement of erythrocytes in the detected laser
light is used to determine arteriolar flow. With the
same probe, white light is introduced into the
tissue and oxygen saturation of haemoglobin was
determined from light absorbed by the haemoglo-
bin in mixed capillary venous blood at a prede-
termined depth from the skin.
3 This study was
therefore aimed at investigating the sequential
changes during mild exercise and recovery in
cardiac function and regional microcirculation of
exercising muscle in diabetes by a method which
allows continuous dynamic monitoring, in order to
capture early cardiac and vascular correlates, which
could ultimately progress to impaired exercise
tolerance. Submaximal exercise is more relevant
as it is equivalent to the 6-minute walk test, used
to evaluate exercise capacity in patients with
marked left ventricular (LV) dysfunction.
4 In
contrast, maximum oxygen consumption
(VO2max) may be compromised because of
reduced patient motivation, poor peripheral blood
flow and impaired skeletal muscle metabolism
with early development of acidosis, besides limita-
tion in cardiac output, correlates only modestly
with this test.
5
STUDY PROTOCOL
Subjects
The investigation conforms to the principles out-
lined in the Declaration of Helsinki.
6 The study
was approved by the institutional review board of
Torrent Research Centre and Veeda Clinical
Research (Ahmedabad, India). After signing the
written informed consent, 127 subjects were
screened. The inclusion criteria were subjects with
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tion and laboratory investigations, who had no history of
breathlessness on exertion or limitation in exercise capacity, and
age-matched controls who were non-diabetic. Subjects with
arrhythmia, significant peripheral vascular disease, retinopathy,
insulin dependence and those with blood pressure (BP) .180/
100 mmHg, were excluded from the study. One-hundred and
one subjects were included in the study and all completed the
exercise protocol. Data from diabetics with glycosylated
haemoglobin (HbA1c) ,8 (n=31), diabetics with HbA1c >8
(n=38) and age-matched normal controls (n=32) were
included in the analysis.
Experimental procedure
At Veeda Clinical Research, after their breakfast subjects had a
brief physical examination, blood samples were collected for
estimation of HbA1c, vascular cell adhesion molecule (VCAM),
N-terminal brain natriuretic propeptide (NTProBNP) and urine
samples for creatinine and microalbumin estimation. Oxygen to
See (O2C, LEA Medizintechnik, Germany) probe LF3 incorpor-
ating Doppler (830 nm) and near infra-red light spectrum (500–
850 nm), which allows measurement at skeletal muscle post-
capillary venular site, was placed on the belly of the
gastrocnemious on one leg. ICG (Bioz, Cardiodynamics, USA)
and electrocardiogram (ECG-Mac5000, GE Healthcare, Germany)
probes were placed on the chest and BP cuff on the arm.
After calibration, continuous measurements were obtained at
baseline in the resting supine position for 10 minutes followed
by the upright position for 10 minutes and then acclimatisation
on the bicycle ergometer (eBike, GE Healthcare, Germany) for
10 minutes. Exercise was for a duration of 10 minutes, at a
constant load of 50 W, on the electrically braked ergometer,
varying rpm to maintain the constant load, which is equivalent
to 4–7 METS. This level of exercise was chosen to simulate a 6-
minute walk test commonly used to evaluate patients with
heart failure in order to determine if it was adequate to evoke
peripheral vascular response to differentiate the diabetic from
non-diabetic subjects. At the end of the exercise period, subjects
were asked to lie supine again for a recovery period of at least
15 minutes. ECG was recorded throughout and BP every
2 minutes. The same protocol was repeated in 10 subjects to
assess the repeatability of the measurements. The entire study
was completed over a period of four months.
Data acquisition and processing
Data from O2C and ICG were acquired for five different
phases—namely, resting supine baseline, standing, sitting on
ergometer, during exercise and recovery after exercise. ICG
measurements (collected every 1 minute) and O2C measure-
ments (collected every 2 seconds were also averaged for 1
minute) were classified and synchronised for different phases of
the protocol. Data were cleaned for machine error and artefacts
(random and during transition from one phase of protocol to
next) for all the measured variables. For O2C parameters, flow
response to exercise was measured as area under the curve
(AUC) and oxygen saturation (SO2) as area over the curve
(AOC) of percentage change at each time point during exercise,
from a mean of sitting. In addition, the slope to achieve
maximum velocity in the microcirculation was computed. ICG
parameters considered for analysis were cardiac output (CO),
stroke volume (SV) and systolic time interval. Systolic time
interval was obtained by summing the pre-ejection period (PEP)
and left ventricular ejection time (LVET) obtained from ICG.
Response during recovery was measured as AUC of the data
points recorded during the recovery phase. Subjects who
completed the exercise phase of 10 minutes were included for
analysis on exercise data (table 1). For analysis on recovery data,
only those who completed exercise followed by 15 minutes of
recovery were included (28 diabetics with HbA1c,8, 35
diabetics with HbA1c >8 and 32 age-matched normal controls).
To calculate oxygen debt for each subject, the value of mean
SO2 at resting supine baseline, multiplied by the same period of
time—that is, 15 minutes, was subtracted from AUC over
15 minutes of recovery.
7 AUC has been calculated using
WinNonlin (Version-5.2).
Statistical analysis
Data are expressed as mean (SD) and graphically represented as
mean (SEM). Statistical analysis has been performed using SAS
(Version-9.1). Demographic data have been tested to see
differences among three groups using ANOVA followed by
post-hoc Dunnett t tests (two-sided). Repeatability was
determined by a two-sided paired t test on AUC values (derived
from percentage change during exercise from sitting baseline) of
the O2C parameters, SO2 and flow and ICG parameter, CO.
Proportions of concomitant medications were subjected to
Fisher’s exact test. CO, SV, time for downward inflection, and
AUC or AOC of percentage change from baseline, during
exercise and for recovery period, was compared between groups
by the one-sided unpaired t test. In the absence of normality,
data were subjected to the non-parametric Wilcoxon test.
Percentage change in systolic time interval over time, of normal,
diabetics with HbA1c ,8 and diabetics with HbA1c >8, were
compared by repeated measures analysis of variance
(RMANOVA). Statistical significance was defined as p value
(0.05.
RESULTS
Demography
The demographic profile of the subjects included in the study is
shown in table 1. Medications, sulphonylurea secretagogues,
thiazolidinedione sensitisers, antihypertensives, angiotensin-
converting enzyme (ACE) inhibitors and angiotensin receptor
blockers (ARBs) and loop diuretics, as well as statins and b-
blockers (table 1), taken by the subjects did not influence the
measurements made during the study. Statins were analysed
separately and did not show an effect on the cardiac response to
exercise when comparing the two diabetic groups. Similarly, the
diabetic group with HbA1c >8, showed a greater attenuation of
the cardiac response to exercise as compared to the diabetic
group with HbA1c ,8. This was probably not secondary to
attenuation of the response due to b-blockers as fewer diabetics
with HbA1c >8 were taking b-blockers compared to those with
HbA1c ,8.
Cardiac response during exercise
Resting CO was lowest in normal individuals and although
statistically not significant, it was slightly higher in the diabetic
groups with HbA1c ,8 and >8. In response to exercise, there
was a rise in both SV and CO in all groups. However, the
capacity to maximally increase CO in response to exercise, a
measure of the cardiac reserve, was significantly (p,0.001)
reduced in the diabetic patients compared to normal subjects
(fig 1A). This could be ascribed to a smaller rise in SV during
exercise in diabetic patients, which was significantly reduced
(p,0.002) in the more severely diabetic group (fig 1B).
Diabetes, lipids and metabolism
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towards reduction of SV, an indicator of inadequate filling
secondary to increasing heart rate, occurred significantly (p,0.05
normal vs ,8; p,0.001 normal vs >8) earlier, and at lower heart
rates (p,0.05 normal vs diabetic groups) in the diabetic groups
compared to normal (fig 2A and 2B). Lengthening of the systolic
time interval was observed in the diabetic group with HbA1c >8,
in that there was a greater compensatory lengthening of the
systolic time interval depicted here as a smaller fall in the systolic
timeforagiven strokeoutputduring exercisecomparedtonormal
(p,0.05) (fig 2C).
Cardiac response during recovery
During the recovery phase after exercise, the CO remained
elevated and did not return to resting baseline. The increase
however was attenuated in diabetics, more so in the diabetics
with HbA1c >8( p ,0.05) (fig 3A). There was no difference in
the heart rate response during recovery between the different
groups.
Skeletal muscle perfusion during exercise
Regional changes in perfusion in the muscle as revealed by local
measurement of flow are shown in figure 4A. There was a
significant (p,0.05) reduction in AUC of percentage change
from baseline in diabetic individuals with HbA1c >8 (1024.7
(780.3)) compared to normal subjects (1433.4 (1055.9)).
Diabetics with HbA1c ,8, on the other hand, did not show a
significant difference; however, to compensate, flow was
slightly increased (1541.1 (1648.1)) compared to normal
(fig 4A). This was accompanied by a reduction in oxygen
saturation in both the diabetic groups compared to normal
(fig 4B). AOC in normal subjects (277.2 (170.8)) was
significantly (p,0.05) more compared to diabetics with HbA1c
,8( 2125.3 (236.1)) and diabetics with HbA1c >8( 2165.6
(247.6)). This was offset, in the diabetics with HbA1c >8, by
increased velocity of blood in the microcirculation, which
showed a significant increase (p,0.05) in the slope to achieve
maximal velocity (slope=3.05 (2.59)), compared to the normal
subjects (slope=2.08 (1.65)).
Table 1 Demographic profile of subjects
Normal (n=32) HbA1C ,8 (n=31) HbA1C >8 (n=38)
Age (years) 48.8 (5.3) 50.6 (7.3) 50.3 (4.6)
BMI (kg/m
2){ 23.81* (3.4) 26.42 (2.8) 26.57 (3.8)
Systolic blood pressure (mmHg) 116 (10) 120 (12) 117 (11)
Diastolic blood pressure (mmHg) 80 (9) 80 (7) 78 (9)
Cardiac output (l/ml) 4.96 (0.95) 5.10 (0.91) 5.19 (0.76)
Heart rate 77 (11) 80 (14) 80 (10)
NT-proBNP (pg/ml){ 31 (14.5–51.5) 35.1 (11.5–62.7) 27.6 (14.6–55.7)
VCAM (ng/ml){ 326.8 (186–647) 343.8 (171–617) 416.9 (253–611)
Diabetes duration (years){ – 4 (3–10) 5 (3–10)
Microalbuminuria (mg/l) 18.99 (44.93) 17.85 (36.35) 41.05 (88.11)
eGFR (ml/min/1.73 m
2) 85 (12) 80 (16) 90 (17)
Concomitant medication
Secretagogues – 70 73
Sensitisers – 73 76
b-blockers{ – 33 5**
Antihypertensives – 50 34
Diuretics – 7 3
Statins – 8.3 0
Values are means (SD) or {median (interquartile range).
*p,0.01 normal vs ,8, normal vs >8; **p,0.05 ,8v s>8.
{Does not alter and contribute to diabetic vs non-diabetic comparison for various ICG and O2C variables.
Figure 1 (A) Cardiac reserve during
exercise and (B) stroke volume reserve
during exercise, the key parameter
limiting increase in cardiac output. CO,
cardiac output; HbA1c, glycosylated
haemoglobin.
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Regional flow to the exercising muscle normally remains
elevated, over resting levels, even after stopping exercise, during
recovery. Compared to normal subjects, in diabetics augmenta-
tion of flow was more (fig 3B), in order to compensate for the
reduced CO response during recovery.
Oxygen debt as determined from the diminished SO2 during
recovery, over the resting baseline, was significantly increased in
the diabetic subjects compared to normal (fig 3C) (p,0.05).
Despite the increase in flow, desaturation of the local flow over
the resting values persisted; however, it was least in the normal
subjects, as evident by highest AUC of oxygen saturation during
recovery. In the diabetic group, SO2 reduced significantly in
both mild and severely diabetic patients (fig 3D).
Repeatability
Data from 10 subjects who repeated the exercise protocol
showed that AUC of percentage change from the sitting
position to exercise did not show any significant difference in
SO2 (507 (158) initial vs 625 (126) repeat, p.0.05), flow (3400
(867) initial vs 3166 (996) repeat, p.0.05) and in CO (75.6
(13.3) initial vs 75.7 (13.8) repeat, p.0.05). Hence, the precision
of the relative measurements before and during exercise were
reasonably accurate for acceptance of O2C and ICG.
Figure 2 (A) Time to downward
inflection of stroke volume response
during exercise demonstrating that with
increasingly poor glycaemic control there
is increasing limitation in the capacity to
augment stroke volume. (B) Heart rate at
downward inflection in stroke volume
during exercise. Increase in cardiac
output occurs as a function of increase in
heart rate with decreasing oxygen pulse
delivered to muscles. (C) Reduction in
systolic time interval compared to
baseline indicating longer systole and
compromised diastole in diabetics.
HbA1c, glycosylated haemoglobin;
RMANOVA, repeated measures analysis
of variance.
Figure 3 (A) Difference in area under
the curve (AUC) of cardiac output (CO)
during recovery from resting baseline:
cardiac output overshoot during recovery.
(B) Increase in regional flow over baseline
during recovery: difference in AUC during
recovery from resting baseline. (C)
Oxygen debt: difference in AUC during
recovery from resting baseline. (D)
Oxygen saturation (AUC) in muscle flow
during recovery. HbA1c, glycosylated
haemoglobin.
Diabetes, lipids and metabolism
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This study characterises the haemodynamic response to exercise
in diabetic individuals compared to normal individuals, by
dynamic recording of cardiac function as well as simultaneous
monitoring of regional perfusion of the muscle. These findings
demonstrate that cardiac response even to submaximal exercise
is attenuated significantly in diabetic individuals.
Simultaneously, there is an attempt to maintain regional
microvascular perfusion by a compensatory augmentation of
regional flow to the exercising muscle. Despite this compensa-
tion, there is greater desaturation of the supply reaching the
working muscle in diabetics compared with normal individuals.
Furthermore, the reduction in cardiac reserve as well as regional
oxygen delivery during exercise, were found to be related to the
severity of diabetes.
Reduced exercise capacity in diabetics has been reported in
subjects with non-insulin dependent diabetes mellitus
(NIDDM) without coronary artery disease
8 and a correlation
between left ventricular dysfunction and impaired exercise
capacity has been demonstrated in diabetics in several studies.
9
Our study confirms that the SV reserve is the key parameter
that is compromised during exercise in asymptomatic diabetic
individuals. This is evident even with the mild exercise
equivalent to a 6-minute walk test when measured dynamically
in ambulatory subjects who are not in failure. The association
of poor glycaemic control with worse cardiac and peripheral
dysfunction in this study is consistent with a previous large
study in asymptomatic type 2 diabetics.
10 Other studies have
shown that A1c has an inverse correlation with maximum
oxygen uptake,
11 work capacity
12 and exercise duration.
13
Perturbation of cardiac function independent of coronary
artery disease and BP in diabetes may result from an interplay of
a wide variety of progressively dysfunctional autoregulatory
mechanisms. Diastolic abnormalities like delayed onset of
ventricular relaxation,
14 and systolic function abnormalities of
the ventricular muscular pump characterised by abnormal
systolic time intervals and by increased brain natriuretic peptide
(BNP) levels, as observed in this study, precede reduced
haemodynamic pump performance with severe systolic and
diastolic abnormalities. Limitations on cardiac reserve and
cardiac contractile function thus restrict the supply from
meeting the demand imposed by exercise. In addition, micro-
circulatory deficits coupled with altered energetics limit the
ability to meet the demand in exercising skeletal muscle in
diabetics.
15 16 Endothelial dysfunction and functional alterations
of the microcirculation, on the other hand, precede morpholo-
gical changes and contribute to an increased vascular perme-
ability
17 and an impaired endothelial vasodilatory response.
There are several reports that insulin also increases sympathetic
nervous system activity, which can determine the nutritive flow
distribution.
18 Diabetes with associated insulin resistance and
autonomic dysfunction could lead to further exacerbation of the
maldistribution locally to fulfil the nutritive flow required to
meet the metabolic demand during exercise. These changes,
acting in conjunction, induce dysfunction with resultant
reductions in flow and O2 delivery at rest and during exercise.
19
A perturbation of intramuscular homeostasis in response to
exercise challenge was also observed in this study, which has the
potential to contribute to premature muscular fatigue and
progress to reduced exercise tolerance in diabetic individuals.
During the recovery period, a shift from carbohydrate to fat
as a fuel substrate occurs to prevent further depletion of muscle
glycogen stores, leading to oxygen consumption remaining
elevated above resting levels after exercise, called oxygen debt,
because the oxygen cost of fat catabolism is greater than that of
carbohydrate catabolism.
20 21 In order to meet this requirement,
a marked increase in stroke volume during early recovery with
overshoot appears to be facilitated by both an immediate
afterload reduction and a relatively slow decrease in cardiac
sympathetic stimulation. Accumulation of a large oxygen debt
during exercise has been reported in heart failure patients.
22 In
this study, overshoot of cardiac output was observed during
recovery, though lower in diabetics and so was the mixed
venous SO2, suggesting more severe muscle underperfusion and
greater O2-deficit and regional ischaemia in diabetic individuals.
A possible mechanism could be a persistence of sympathetic
activity, which serves to increase vascular resistance in non-
working tissues during exercise, which the local metabolic
factors and endothelium-derived substances such as nitric oxide
and prostaglandins are unable to over-ride, as they are deficient
in the diabetic state. Increased renin-angiotensin-endothelin
system activity may also contribute, at least in part.
Mediators of the changes underlying impaired exercise
response in patients with type 2 diabetes are multiple. Limited
exercise tolerance has been associated with poor glycaemic
control.
8 10–12 23 Secondary to this, glycosylation leading to the
formation of AGE (advanced glycation endproduct), initiate a
proinflammatory and procoagulant state and may impair the
function of a number of proteins leading to cardiac, vascular or
endothelial dysfunction.
24 25 We have found that diabetes-
induced myocardial dysfunction in a diabetic hypertensive rat
model was reversed by reducing the AGE burden consequent to
treatment with AGE-breaker.
26
Previous reports of ICG in diabetics have been limited and
restricted to measurements at rest. One ICG study in diabetic
individuals revealed that thoracic fluid content increased despite
improvement in contractile indices after treatment with rosigli-
tazone.
27 In another study, no difference was detected in cardiac
index at rest between healthy individuals and newly diagnosed
diabetics,
28 indicating that possibly exercise provocation would be
Figure 4 (A) Regional muscle flow
during exercise and (B) oxygen saturation
in blood supplied to exercising muscle.
Note that in diabetics with reasonable
control increase in flow is not able to
contain desaturation. Diabetics with poor
control show limited capacity to augment
flow and run up a steeper oxygen debt
with a late attempt at correction which
could be due to local factors over-riding
systemic vascular tone. HbA1c,
glycosylated haemoglobin.
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namics. Insights on the control of muscle blood flow and oxygen
consumption during exercise have, in the past, relied on
measurements of bulk flow in large conduit arteries to the
exercising limbs precluding analysis of local perfusion and
oxygenation mismatch. However, comparing changes during rest,
dynamicexerciseandrecoveryafterexercisewithacombinationof
NIRS, laser Doppler and impedance cardiography to expose
subclinical differences in diabetic individuals has not been
attempted previously to the best of our knowledge.
Repeatabilityofthemeasurementsshowedreasonableconsistency
between measurements made on both O2C and ICG parameters.
The potential limitations of our study are the mixed diabetic
population studied, which could have incipient complications
like neuropathy, peripheral vascular disease and coronary artery
disease, which could be influencing the study parameters. For
diabetic subjects without any signs of heart failure, reduction in
exercise capacity secondary to reduction in cardiac output may
be evident only during maximal exercise and could be of
prognostic significance. We also do not have tissue-Doppler data
to correlate limitation in increasing stroke volume to diastolic
dysfunction.
CONCLUSION
In summary, this cross-sectional study in a diabetic population
showed that by combining the assessment of dynamic cardiac
response during exercise with peripheral flow distribution and
nutritive perfusion, subclinical differences in haemodynamic
response were detected in diabetic individuals, hitherto not
reported to the best of our knowledge. Longitudinal follow-up
of these patients and a comparison of dynamic cardiac response
and that of peripheral flow and nutritive distribution, as
described, with the traditional measures of exercise capacity,
which have been studied longitudinally over time and shown to
have prognostic significance, would provide an objective and
sensitive measure of cardiac and microvascular correlates of the
composite haemodynamic function and indicate the suitability
of such diagnostic measures for early detection of a population
at risk of progressing to heart failure.
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